Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer

被引：0
|
作者：
Pereira, Marina A. [1 ]
Ramos, Marcus Fernando Kodama P. [1 ]
Ribeiro e Ribeiro, Renan [1 ]
Dias, Andre R. [1 ]
Ribeiro, Ulysses, Jr. [1 ]
Zilberstein, Bruno [1 ]
Cecconello, Ivan [1 ]
Mello, Evandro Sobroza [1 ]
Castria, Tiago B. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Canc, Sao Paulo, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2020年 / 231卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E208 / E208
页数：1
相关论文
共 50 条
  • [1] Programmed Death Ligand-1 (PD-L1) Expression and Prognostic Value in Synovial Sarcoma
    Kozak, K.
    Rembiszewska, A.
    Podgorska, A.
    Kosela-Paterczyk, H.
    Przybyl, J.
    Gos, A.
    Switaj, T.
    Wagrodzki, M.
    Prochorec-Sobieszek, M.
    Rutkowski, P.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S148 - S148
  • [2] PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION AND PROGNOSTIC VALUE IN SYNOVIAL SARCOMA
    Kozak, K.
    Szumera-Cieckiewicz, A.
    Rembiszewska, A.
    Podgorska, A.
    Paterczyk, H. M. Kosela
    Przybyl, J.
    Gos, A.
    Switaj, T.
    Prochorec-Sobieszek, M.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer
    Wang, Lisha
    Ren, Fei
    Wang, Qifeng
    Baldridge, Lee Ann
    Monn, M. Francesca
    Fisher, Kurt W.
    Sheng, Weiqi
    Zhou, Xiaoyan
    Du, Xiang
    Cheng, Liang
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (02) : 175 - 181
  • [4] Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer
    Lisha Wang
    Fei Ren
    Qifeng Wang
    Lee Ann Baldridge
    M. Francesca Monn
    Kurt W. Fisher
    Weiqi Sheng
    Xiaoyan Zhou
    Xiang Du
    Liang Cheng
    Molecular Diagnosis & Therapy, 2016, 20 : 175 - 181
  • [5] Profile of programmed death ligand-1 (PD-L1) expression and PD-L1 gene amplification in Indonesian colorectal cancer patients.
    Budiyati, Akterono Dwi
    Putra, Teguh Pribadi
    Kusumo, Gita Dewi
    Rexana, Fritzie
    Kurniawan, Antonius
    Sudoyo, Aru Wisaksono
    Utomo, Ahmad Rusdan
    Utama, Andi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [6] Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
    Wu, Changping
    Zhu, Yibei
    Jiang, Jingting
    Zhao, Jiemin
    Zhang, Xue-Guang
    Xu, Ning
    ACTA HISTOCHEMICA, 2006, 108 (01) : 19 - 24
  • [7] Programmed death ligand-1 (PD L-1) expression in cervical cancer patients
    L, A. S.
    Lakshmi, S.
    Preethi, T. R.
    Mathew, A.
    Kumar, A.
    Joseph, J.
    Mathews, S.
    James, F. V.
    ANNALS OF ONCOLOGY, 2020, 31 : S643 - S643
  • [8] Prognostic Value of Programmed Cell Death 1 Ligand-1 (PD-L1) or PD-1 Expression in Patients with Osteosarcoma: A Meta-Analysis
    Huang, Xin
    Zhang, Weiyue
    Zhang, Zhicai
    Shi, Deyao
    Wu, Fashuai
    Zhong, Binlong
    Shao, Zengwu
    JOURNAL OF CANCER, 2018, 9 (14): : 2525 - 2531
  • [9] Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma
    Wang, Jennifer
    Rodriguez, Jaime
    Rao, Priya
    Pettaway, Curtis Alvin
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [10] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
12345